The NSW Hepatitis B Strategy 2023-2026 provides a system-wide framework for NSW Health and partners to respond to hepatitis B from 2023 to 2026. NSW has committed to supporting National and World Health Organization (WHO) strategic goals to eliminate hepatitis B as a public health concern by 2030. The Strategy outlines priorities for hepatitis B prevention, early diagnosis and care, as well as how NSW can improve access and equity to services.
The Strategy identifies key focus areas, which are to ensure:
The Strategy focuses efforts on priority populations including:
Information regarding co-payments for medicines used in the treatment of hepatitis B, including prescriber accreditation and patient content forms is available from the
Co-payments for Section 100 website.